Skip to main content
ETON logo

ETON

Eton Pharmaceuticals, Inc.
$37.74 -0.28 (-0.74%) At close · Jul 7
Market Cap
$1.03B
Shares
27,392,358

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$79.95M +104.9%
FY2025 Revenue FY2019–FY2025
Net Income
-$4.6M -20.4%
FY2025 Net Income FY2018–FY2025
Gross Margin
53.46% -6.6pp
FY2025 Gross Margin FY2019–FY2025
Operating Margin
-1.06% +5.6pp
FY2025 Operating Margin FY2019–FY2025
Operating Cash Flow
$10.52M +986.1%
FY2025 Operating Cash Flow FY2018–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
at least $120M $86.93M $79.95M $39.01M $31.64M $21.25M $21.83M $39K $959K
$39.32M $37.21M $15.6M $10.58M $6.93M $286K $453K
$47.61M $42.74M $23.41M $21.06M $14.32M $19.21M -$247K $506K
53.46% 60.01% 66.56% 67.38% 87.99% -633.33% 52.76%
$8.48M $7.77M $3.26M $3.32M $4M $6.24M $14.1M $11.56M $5.63M
$37.1M $35.82M $22.75M $18.93M $18.58M $14.47M $12.76M $7.55M $4.69M
$4M $1.1M $790K $1.62M $204K $150K
$4.04M $1.15M $901K $66K $155K $651K $447K $63K
$45.57M $43.58M $26.01M $22.25M $22.58M $20.7M $26.86M $19.11M $10.32M
$2.04M -$844K -$2.6M -$1.19M -$8.26M -$1.5M -$27.11M -$18.6M -$10.32M
-1.06% -6.66% -3.77% -38.87% -6.85% -69515.38% -1939.62%
$3.2M -$1.45M -$291K -$8.19M -$1.34M -$26.46M -$18.15M -$10.26M
$1.06M $955K $1.04M $884K
-$3.71M -$1.21M $503K -$761K -$1.01M -$859K
-$1.49M -$4.56M -$3.81M -$689K -$9.02M -$1.96M -$27.97M -$18.32M -$12.74M
-$11K $43K $15K $247K
-$1.48M -$4.6M -$3.82M -$936K -$9.02M -$1.96M -$27.97M -$18.32M -$12.74M
-5.75% -9.8% -2.96% -42.45% -8.95% -71717.95% -1910.32%
-$27.97M -$18.32M -$37.23M
USD/shares -$0.17 -$0.15 -$0.04 -$0.36
shares 26.91M 25.9M 25.65M 25.15M 25.21M 21.01M 17.76M 6.42M
shares 25.21M 21.01M 17.76M 6.42M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Product Sales and Royalties $76,664,000 $38,511,000 $26,142,000 $11,251,000 $2,832,000
License $3,286,000 $500,000 $5,500,000 $10,000,000 $19,000,000
Licensing Revenue $500,000
Product Sales And Royalties $39,000
Product $459,000
Key facts CIK 1710340 CUSIP 29772L108 13F (30d) 5 filings 5 filers Visit website Investor relations